Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
Open Access
- 4 July 2020
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (7) , 624
Abstract
Mismanagement of bacterial infection therapies has undermined the reliability and efficacy of antibiotic treatments, producing a profound crisis of the antibiotic drug market. It is by now clear that tackling deadly infections demands novel strategies not only based on the mere toxicity of anti-infective compounds. Host-directed therapies have been the first example as novel treatments with alternate success. Nevertheless, recent advances in the human microbiome research have provided evidence that compounds produced by the microbial metabolism, namely postbiotics, can have significant impact on human health. Such compounds target the host-microbe-pathogen interface rescuing biotic and immune unbalances as well as inflammation, thus providing novel therapeutic opportunities. This work discusses critically, through literature review and personal contributions, these novel nonantibiotic treatment strategies for infectious disease management and resistance prevention, which could represent a paradigm change rocking the foundation of current antibiotic therapy tenets.Keywords
Funding Information
- Fondazione per la Ricerca sulla Fibrosi Cistica (FFC#24/2018)
This publication has 300 references indexed in Scilit:
- Lactobacillus fermentum, a pathogen in documented cholecystitisInternational Journal of Surgery Case Reports, 2013
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− miceNature, 2012
- Signaling-mediated bacterial persister formationNature Chemical Biology, 2012
- The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid CellsImmunity, 2012
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid LoadingCell Metabolism, 2011
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian ColonCell Metabolism, 2011
- Essential Role for Retinoic Acid in the Promotion of CD4+ T Cell Effector Responses via Retinoic Acid Receptor AlphaImmunity, 2011
- Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammationMolecular Immunology, 2011
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008